Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies to CD40 with enhanced agonist activity

Antibodies to CD40 with enhanced agonist activity

US Patent 10479838 · Granted Nov 19, 2019

Estimated economic value: $257,753,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glypican-3-binding fibronectin based scaffold molecules2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Anti-inflammatory polypeptides2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Nectin-4 antibody conjugates and uses thereof2025
Antibodies against TIM3 and uses thereof2025
Compositions of protein complexes and methods of use thereof2025
Immune complex2025
Antibodies against TIM3 and uses thereof2024
Antibodies and antigen binding peptides for factor XIa inhibitors and uses there2024
Antibodies to TIGIT2024